tiprankstipranks
Madrigal (MDGL)
:MDGL
US Market

Madrigal Pharmaceuticals (MDGL) Ownership - Who Owns Madrigal Pharmaceuticals?

Compare
1,231 Followers

Madrigal Pharmaceuticals (MDGL) Ownership Overview

19.56%27.43%0.07%14.90%38.03%
19.56% Insiders
0.07% Other Institutional Investors
14.90% ETFs
38.03% Public Companies and
Individual Investors
The ownership structure of Madrigal Pharmaceuticals (MDGL) stock is a mix of institutional, retail, and individual investors. Approximately 42.41% of the company’s stock is owned by Institutional Investors, 19.56% is owned by Insiders, and 38.03% is owned by Public Companies and Individual Investors.
The ownership structure of Madrigal Pharmaceuticals (MDGL) stock is a mix of institutional, retail, and individual investors. Approximately 27.50% of the company’s stock is owned by Institutional Investors, 19.56% is owned by Insiders, and 14.90% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 14, 2025
Fred Craves
Director
xxxxxxxxxxxxx
$5082372
Mar 07, 2025
Robert E. Waltermire
Svp, Chief Pharma Dev
xxxxxxxxxxxxx
$4817012
Mar 05, 2025
Mardi Dier
Svp And Cfo
xxxxxxxxxxxxx
$386831
Mar 04, 2025
Robert E. Waltermire
Svp, Chief Pharma Dev
xxxxxxxxxxxxx
$418480

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$203347
Dec 31, 2024
xxxxxxxxxxxxx
$11160359
Dec 31, 2024
xxxxxxxxxxxxx
$95384232

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,042,000Institution9.25%711,330,700
1,974,590Institution8.94%687,848,427
1,794,831Insider8.13%625,229,379
1,614,288Institution7.31%562,337,225
1,467,879Institution6.65%511,335,650
1,422,141Institution6.44%495,402,817
1,116,584Insider5.06%388,962,036
841,989Insider3.81%293,306,868
825,152Institution3.74%287,441,699
383,547Insider1.74%133,608,597

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,467,879Institution6.65%511,335,650
1,422,141Institution6.44%495,402,817
272,634Institution1.23%94,972,054
197,639Institution0.90%68,847,546
192,777Institution0.87%67,153,868
189,988Institution0.86%66,182,320
153,039Institution0.69%53,311,136
137,884Institution0.62%48,031,891
135,295Institution0.61%47,130,013
112,700Institution0.51%39,259,045

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
517,042Institution2.34%176,450,923
483,534Institution2.19%168,439,069
416,579Institution1.89%128,543,782
347,087Institution1.57%112,116,043
275,186Institution1.25%93,912,726
259,284Institution1.17%88,485,851
158,190Institution0.72%55,105,487
112,051Institution0.51%39,032,966
82,316Institution0.37%28,091,981
79,789Institution0.36%25,773,443

FAQ

Who Owns Madrigal (MDGL)?
According to the latest TipRanks data, approximately 0.07% of the company's stock is held by institutional investors, 19.56% is held by insiders, and 38.03% is held by retail investors.
    What percentage of Madrigal (MDGL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.07% of Madrigal (MDGL) stock is held by institutional investors.
      What percentage of Madrigal (MDGL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 38.03% of Madrigal (MDGL) stock is held by retail investors.
        Who owns the most shares of Madrigal (MDGL)?
        John Paulson owns the most shares of Madrigal (MDGL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis